Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Talis Biomedical stock

Learn how to easily invest in Talis Biomedical stock.

Talis Biomedical Corp is a medical devices business based in the US. Talis Biomedical shares (TLIS) are listed on the NASDAQ and all prices are listed in US Dollars. Talis Biomedical employs 242 staff and has a trailing 12-month revenue of around 0.00.

How to buy shares in Talis Biomedical

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – TLIS – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Talis Biomedical stock price (NASDAQ: TLIS)

Use our graph to track the performance of TLIS stocks over time.

Talis Biomedical shares at a glance

Information last updated 2022-06-25.
Latest market close$0.84
52-week range$0.80 - $12.88
50-day moving average $1.03
200-day moving average $3.19
Wall St. target price$1.00
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-6.33

Buy Talis Biomedical shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 5 of 5
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
Finder Award
eToro
Stocks, ETFs, Cryptocurrency
$0
$10
$10
when you sign up and deposit $100
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, or TN.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.
SoFi Invest
Stocks, ETFs, Cryptocurrency
$0
$1
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Tastyworks
Stocks, Options, ETFs, Cryptocurrency
$0
$0
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$0
$0
$125 - $625
when you open and fund an account with $25,000 - $250,000+
INVESTMENT AND INSURANCE PRODUCTS ARE: NOT A DEPOSIT • NOT FDIC INSURED • NO BANK GUARANTEE • MAY LOSE VALUE
Axos Bank Self Directed Investing
Stocks
$0
$1,000
$150
when you open an account and deposit at least $1500.
loading

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Talis Biomedical stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Talis Biomedical price performance over time

Historical closes compared with the close of $0.835 from 2022-07-01

1 week (2022-06-24) 2.58%
1 month (2022-06-03) -18.93%
3 months (2022-04-01) -42.01%
6 months (2022-01-03) -80.07%
1 year (2021-07-02) -91.80%
2 years (2020-06-29) N/A
3 years (2019-06-29) N/A
5 years (2017-06-29) N/A

Talis Biomedical financials

Revenue TTM $4.4 million
Gross profit TTM $-149,398,000
Return on assets TTM -32.4%
Return on equity TTM -58.88%
Profit margin 0%
Book value $7.62
Market capitalisation $21.7 million

TTM: trailing 12 months

Talis Biomedical share dividends

We're not expecting Talis Biomedical to pay a dividend over the next 12 months.

Talis Biomedical overview

Talis Biomedical Corporation operates as a molecular diagnostic company. The company is developing the Talis One system to address limitations of existing point-of-care diagnostic testing technologies for infectious diseases. It also offers Talis One COVID-19 Test System, which focuses on detection of SARS-CoV-2, the virus that causes COVID-19. In addition, it develops Talis One assay kit for respiratory infections, infections related to women's health, and sexually transmitted infections; and other tests for the detection of other respiratory infections, such as a respiratory panel test to detect influenza A, influenza B, and respiratory syncytial virus. Talis Biomedical Corporation was incorporated in 2013 and is headquartered in Menlo Park, California. .

Frequently asked questions

What percentage of Talis Biomedical is owned by insiders or institutions?
Currently 10.338% of Talis Biomedical shares are held by insiders and 63.593% by institutions.
How many people work for Talis Biomedical?
Latest data suggests 242 work at Talis Biomedical.
When does the fiscal year end for Talis Biomedical?
Talis Biomedical's fiscal year ends in December.
Where is Talis Biomedical based?
Talis Biomedical's address is: 230 Constitution Drive, Menlo Park, CA, United States, 94025
What is Talis Biomedical's ISIN number?
Talis Biomedical's international securities identification number is: US87424L1089

More guides on Finder

Ask an Expert

You are about to post a question on finder.com:

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • finder.com is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked

Finder.com provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and finder.com Terms of Use.

Questions and responses on finder.com are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site